Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
73M
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
54.4M
-
Shares change
-
+1.84M
-
Total reported value, excl. options
-
$119M
-
Value change
-
+$4.1M
-
Put/Call ratio
-
2.14
-
Number of buys
-
67
-
Number of sells
-
-46
-
Price
-
$2.19
Significant Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) as of Q4 2024
145 filings reported holding VTYX - Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.4M shares
of 73M outstanding shares and own 74.55% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (4.5M shares), CITADEL ADVISORS LLC (4.48M shares), BANK OF AMERICA CORP /DE/ (4.27M shares), Sio Capital Management, LLC (4.05M shares), UBS Group AG (3.78M shares), VANGUARD GROUP INC (3.51M shares), TANG CAPITAL MANAGEMENT LLC (3.1M shares), MORGAN STANLEY (2.51M shares), Vestal Point Capital, LP (2M shares), and Point72 Asset Management, L.P. (1.78M shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.